Code | 5238E | ||||||||||
MA number | EU/1/12/797/003 | ||||||||||
Product Form: | sol inj 1x0,263 ml/30,1 mg (liek.inj.skl.+filtr.ihla) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Bayer AG, Germany | ||||||||||
Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Intravitreal use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 22.11.2012 |
SmPC + PL: |
|
Dokument: |
|
Dokument: |
|
Dokument: |
|
Dokument: |
|
Dokument: |
|
Dokument: |
|
Safety feature | Yes |
Data update: | 11.01.2024 |